Administration occupational activities
Federal Judge Orders Trump Administration to Comply with Ruling Against Federal Funding Freeze
federal funding freeze, court order violation, Judge John McConnell, Trump administration, state attorneys general, federal grants, compliance
Trump Administration Targets Massive Cuts to Federal Health Workforce
federal health workers, layoffs, Trump administration, HHS, FDA, healthcare agencies, workforce reduction, government downsizing
Senator Cassidy’s Crucial Vote Advances RFK Jr.’s HHS Secretary Nomination
Robert F. Kennedy Jr., Bill Cassidy, HHS Secretary nomination, Senate Finance Committee, vaccine safety, public health, Trump administration
Astellas Pharma Announces Major Management Restructuring Amid Strong Financial Performance
Astellas Pharma, management restructuring, financial results, executive appointments, pharmaceutical industry
AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction
AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry
2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes
AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration
Senate Grills RFK Jr. on Controversial Health Stances in Contentious HHS Secretary Confirmation Hearings
Robert F. Kennedy Jr., HHS Secretary nomination, Senate confirmation hearings, vaccine skepticism, chronic disease focus, public health policy, Trump administration
Tris Pharma’s Cebranopadol Shows Promising Results in Phase 3 Trial for Moderate-to-Severe Acute Pain Treatment
Cebranopadol, Tris Pharma, ALLEVIATE-1, Phase 3 Clinical Trial, Acute Pain Treatment, Dual-NMR Agonist, Opioid Crisis, Pain Management
Trump Revokes Biden’s Executive Order on AI Safety and Trustworthiness
AI Safety, Biden Executive Order, Trump Administration, Artificial Intelligence Governance, AI Regulation
Understanding the Second Round of Medicare Drug Price Negotiations: What Trump’s CMS Can and Can’t Change
Medicare drug price negotiation, Trump administration, CMS, Inflation Reduction Act, drug prices, negotiation process